Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

AKBA holding history

Akebia Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKBA overviewAll 13F holders of AKBAFull Q2 2026 holdings

Shares (Q2 2026)
1,223,963
Value
$1.40M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AKBA by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,223,963$1.40M<0.1%−609,165−33.2%ReducedHolders
Q1 20261,833,128$2.55M<0.1%−1,760,005−49.0%ReducedHolders
Q4 20253,593,133$5.78M<0.1%−359,594−9.1%ReducedHolders
Q3 20253,952,727$10.8M<0.1%−241,700−5.8%ReducedHolders
Q2 20254,194,427$15.3M<0.1%+188,600+4.7%AddedHolders
Q1 20254,005,827$7.69M<0.1%+182,300+4.8%AddedHolders
Q4 20243,823,527$7.26M<0.1%+105,727+2.8%AddedHolders
Q3 20243,717,800$4.91M<0.1%−197,000−5.0%ReducedHolders
Q2 20243,914,800$3.99M<0.1%+262,700+7.2%AddedHolders
Q1 20243,652,100$6.68M<0.1%−1,127,283−23.6%ReducedHolders
Q4 20234,779,383$5.93M<0.1%+1,623,956+51.5%AddedHolders
Q3 20233,155,427$3.60M<0.1%−175,300−5.3%ReducedHolders
Q2 20233,330,727$3.05M<0.1%+992,227+42.4%AddedHolders
Q1 20232,338,500$1.31M<0.1%−547,727−19.0%ReducedHolders
Q4 20222,886,227$1.67M<0.1%−130,200−4.3%ReducedHolders
Q3 20223,016,427$954.0K<0.1%+1,534,127+103.5%AddedHolders
Q2 20221,482,300$523.0K<0.1%+478,973+47.7%AddedHolders
Q1 20221,003,327$720.0K<0.1%+380,300+61.0%AddedHolders
Q4 2021623,027$1.41M<0.1%−326,900−34.4%ReducedHolders
Q3 2021949,927$2.74M<0.1%−877,803−48.0%ReducedHolders
Q2 20211,827,730$6.93M<0.1%+757,149+70.7%AddedHolders
Q1 20211,070,581$3.62M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.